Commentary

When it’s time to purchase software, how does a CIO avoid cursing the software vendor and wondering how he ended up with such an inflexible piece of junk? Guest columnist and IT strategy consultant Patrick Gray offers five tips to help your organization cut through...

The transitions from Windows XP to Vista, and from cell phones to iPhones, are consistent with the cultural transition we've already made from Web 1.0 to Web 2.0 and beyond, according to Tech/Know columnist Troy Janisch. That great beyond will arrive when computers help us...

Big Pharma has evolved into “Enormous Pharma” thanks to a six-stage deconstruction process of interconnected events, according to Yer Biotech Blues columnist Michael Rosen. Enormous Pharma will likely grow even larger as it is fed by global demographic trends and the need to conquer new...

Just in case the thought never crossed your mind, starting a business can be a taxing proposition, and business taxes are the subject of attorney Joe Boucher's latest edition of Early Stage. In this sixth installment of the Early Stage series, Boucher walks you through...

As is the case with most major reform efforts, it looks as though healthcare reform will be led by the states, writes Inside Wisconsin columnist Tom Still. Gov. Jim Doyle has urged the Legislature to work with him to expand access and lower costs, and...

Having a national broadband strategy is good, but having one that is realistic is even better, according to columnist James Carlini. In this edition of Carlini's Comments, he calls on national lawmakers to “get it right" this time because the Telecom Act of 1996 was...

Western Wisconsin is no longer just for farmers and tourists - it is going high tech. As Inside Wisconsin columnist Tom Still explains, the spill over from the Twin Cities explains some of the growth, but a commitment to regional cooperation, which should be adopted...

Ushering in a new age, DEMO Letter columnist Chris Shipley recently addressed the DEMO 2007 Conference in California, and once again reminded those in attendance that technology consumers are in charge. Not that they needed much reminding, as nearly 70 new products on display provided...

What's the prognosis for GE's recent acquisition of Abbott's diagnostic units? While there are many synergies, the one missing piece for both companies is deploying IT solutions to integrate evidence and data, according to MedTech Futures columnist Dr. Ogan Gurel. Perhaps there is one more...

Next Generation columnist Tony DiRomualdo is back after a holiday hiatus, and he is taking note of the latest episode of “CEOs Gone Wild” featuring Bob Nardelli, who was asked to leave Home Depot. A bitter pill to swallow, he writes, but $210 million worth...